GO2 for Lung Cancer to honor Lilly at San Francisco gala

GO2 for Lung Cancer will recognize Lilly with its Excellence Award in Advancing Innovative Precision Medicine at the Simply the Best Gala on Nov. 14 in San Francisco. The event will also raise funds for research, screening, support and advocacy as lung cancer remains the leading cause of cancer death in the U.S.

Why it matters: - Lung cancer remains the leading cause of cancer death in the United States. - Precision medicine and comprehensive biomarker testing are changing how lung cancer is treated. - GO2 for Lung Cancer uses gala proceeds to support research, screening, care navigation and advocacy that can improve survival and quality of life.

What happened: - GO2 for Lung Cancer will honor Lilly at its annual Simply the Best Gala on Saturday, Nov. 14, at the Fairmont San Francisco. - Lilly will receive the GO2 Excellence Award in Advancing Innovative Precision Medicine. - The award recognizes Lilly’s work in advancing biomarker testing and targeted treatments for people with lung cancer at every stage of care. - GO2 said the annual San Francisco event brings together industry partners, researchers, doctors, nurses, survivors, advocates, funders and individual supporters.

The details: - GO2 said the gala highlights progress across the lung cancer community while raising critical funds for its programs. - Proceeds support patient-centered research, expanded access to screening and high-quality care, personalized support and navigation, and policy and funding advocacy. - GO2 said advances in precision medicine have transformed care by helping treatment decisions reflect the unique characteristics of an individual’s cancer. - The organization said continued research, innovation and access remain critical to improving survival. - The event has been held for more than two decades in San Francisco. - More information is available on the gala page.

Between the lines: - The honor signals how central biomarker testing has become to lung cancer care. - The gala also serves as a fundraising moment for a disease area where better access to testing and targeted treatment can still shape outcomes. - GO2 is using the event to connect recognition of progress with the need for broader access to those advances.

What's next: - GO2 will hold the 2026 Simply the Best Gala on Nov. 14. - Funds raised from the event will go toward GO2’s ongoing programs and advocacy efforts. - The organization said it will continue pushing for research, education, support and policy changes that improve outcomes for people impacted by lung cancer.

The bottom line: - GO2 is turning its annual gala into both a recognition event and a funding engine for precision medicine progress in lung cancer care.